Skip to main content

PRF 425 Pill - white capsule/oblong, 23mm

Pill with imprint PRF 425 is White, Capsule/Oblong and has been identified as Propafenone Hydrochloride Extended-Release 425 mg. It is supplied by Aurobindo Pharma Limited.

Propafenone is used in the treatment of Atrial Fibrillation; Atrial Flutter; Ventricular Tachycardia; Wolff-Parkinson-White Syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PRF 425

Propafenone Hydrochloride Extended-Release

Imprint
PRF 425
Strength
425 mg
Color
White
Size
23.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)
59651-0278

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.